
2.22 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.65 Today|||52-Week Range 2.41 | +123.56% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $249.3M |
X4 Pharmaceuticals, Inc. 61 North Beacon Street Boston Massachusetts 02134 |
Paula S. Ragan | President, Chief Executive Officer & Director |
Mary DiBiase | Chief Operating Officer |
Adam S. Mostafa | Chief Financial Officer, Secretary & Treasurer |
Murray Willis Stewart | Director & Chief Medical Officer |
Art Taveras | Chief Scientific Officer |